Improved filter method for urine sediment detection of urothelial carcinoma by fluorescence in situ hybridization

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 10, 2007, Pages 1574-1577

  Meiers, Isabelle ^a   Singh, Harpreet ^a   Hossain, Deloar ^a   Lang, Kevin ^a   Liu, Lina ^a   Qian, Junqi ^a   Verhest, Alain P ^b   Bostwick, David G ^a  

^a BOSTWICK LABORATORIES   (United States)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE;

ANALYTIC METHOD; ARTICLE; BIOPSY TECHNIQUE; BLADDER BIOPSY; CANCER DIAGNOSIS; CENTRIFUGATION; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9P; CONTROLLED STUDY; CYSTOSCOPY; CYTOSPIN METHOD; DECANTATION; EARLY DIAGNOSIS; EQUIPMENT; FILTER METHOD; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; URINARY TRACT CARCINOMA; URINE SEDIMENT; UROTHELIUM; UROTHELIUM CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; CYTODIAGNOSIS; FILTRATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY BLADDER NEOPLASMS;

EID: 35349004205     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Donat SM. Evaluation and follow-up strategies for superficial bladder cancer. Urol Clin North Am. 2003;30:765-776.
3. Lee R, Droller MJ. The natural history of bladder cancer: implications for therapy. Urol Clin North Am. 2000;27:1-13.
4. Dalbagni G, Herr H. Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer. Urol Clin North Am. 2000;27:137-146.
5. Reuter VE, Melamed MR. The lower urinary tract. In: Sternberg SS, ed. Diagnostic Surgical Pathology. New York, NY: Raven Press; 1994:1767-1805.
6. Soloway MS. Overview of treatment of superficial bladder cancer. Urology. 1985;26:18-26.
7. Heney NM, Ahmed S, Flanagan MJ, et al. Superficial bladder cancer: progression and recurrence. J Urol. 1983;130:1083-1086.
8. Saad A, Hanbury D, McNicholas T, et al. A study comparing various non-invasive methods of detecting bladder cancer in urine. BJU Int. 2002;89:369-373.
9. Walker L, Liston TG, Lloyd-Davies RW. Does flexible cystoscopy miss more tumours than rod-lens examinations? Br J Urol. 1993;72:449-450.
10. Ro JY, Staerkel GA, Ayala AG. Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am. 1992;19:435-453.
11. Halling KC, King W, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000;164:1768-1775.
12. Lubbe L, Nowack R, May M, et al. FISH - a new noninvasive method for the diagnosis of urinary bladder carcinomas. Clin Lab. 2004;50:395-402.
13. Laudadio J, Keane TE, Reeves HM, et al. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int. 2005;96:1280-1285.
14. King W, Proffitt J, Morrison L, et al. The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management. Mol Diagn. 2000;5:309-319.
15. Cajulis RS, Haines GK III, Frias-Hidvegi D, et al. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn Cytopathol. 1995;13:214-224.
16. Meloni AM, Peier AM, Haddad FS, et al. A new approach in the diagnosis and follow-up of bladder cancer: FISH analysis of urine, bladder washings, and tumors. Cancer Genet Cytogenet. 1993;71:105-118.
17. Meloni AM, Peier AM, Kingsley KL. FISH studies of urinary cells of patients with bladder cancer. Urol Oncol. 1995;1:234-239.
18. Junker K, Hartmann A, Tanke HJ, et al. Evaluation of a multi-color fluorescence in situ hybridization assay for the detection of bladder cancer - results from three European laboratories. J Urol. 2002;167:A657,164-165.
19. Sarosdy MF, Schellhammer P, Bokinsky G, et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol. 2002;168:1950-1954.
20. Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol. 2003;169:2101-2105.
21. Skacel M, Pettay JD, Tsiftsakis EK, et al. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. Anal Quant Cytol Histol. 2001;23:381-387.
22. Bollmann M, Heller H, Bankfalvi A, et al. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer? BJU Int. 2005;95:1219-1225.
23. Mian C, Lodde M, Comploj E, et al. Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion multicolour-FISH in the detection of urothelial carcinoma. Cytopathology. 2003;14:338-342.
24. Kipp BR, Campion MB, Coffman E, et al. An evaluation of ThinPrep UroCyte filters for the preparation of slides for fluorescence in situ hybridization. Diagn Cytopathol. 2006;34:479-484.
25. Bastacky S, Ibrahim S, Wilczynski SP, et al. The accuracy of urinary cytology in daily practice. Cancer. 1999;87:118-128.